Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 1:39 pm Sale | 2025-06-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 682,857 42.700% | -25,911 (-3.66%) | Filing History |
| 2025-07-29 1:01 pm Sale | 2025-06-30 | 13G | Rapid7, Inc. RPD | UBS Group AG | 0 0.000% | -3,345,168 (Position Closed) | Filing History |
| 2025-05-01 06:24 am Sale | 2025-03-31 | 13G | Rapid7, Inc. RPD | UBS Group AG | 3,345,168 5.200% | -596,369 (-15.13%) | Filing History |
| 2025-04-30 4:41 pm Unchanged | 2025-03-31 | 13G | RENALYTIX PLC ADS RNLXY | UBS Group AG | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-30 4:15 pm Sale | 2024-12-31 | 13G | RENALYTIX PLC ADS RNLXY | UBS Group AG | 0 0.000% | -16,774,708 (Position Closed) | Filing History |
| 2025-04-30 3:52 pm Sale | 2025-03-31 | 13G | PIMCO Access Income Fund PAXS | UBS Group AG | 0 0.000% | -2,233,985 (Position Closed) | Filing History |
| 2025-04-30 3:48 pm Sale | 2025-03-31 | 13G | Zeta Network Group ADD | UBS Group AG | 0 0.000% | -1,486 (Position Closed) | Filing History |
| 2025-04-30 3:31 pm Purchase | 2025-03-31 | 13G | Western Asset Investment Grade Defined Opportunity Trust Inc. IGI | UBS Group AG | 345,414 5.800% | 345,414 (New Position) | Filing History |
| 2025-04-30 2:46 pm Sale | 2025-03-31 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 708,768 44.300% | -41,551 (-5.54%) | Filing History |
| 2025-04-30 11:44 am Sale | 2025-03-31 | 13G | Infinera Corporation INFN | UBS Group AG | 0 0.000% | -14,484,028 (Position Closed) | Filing History |
| 2025-04-25 2:33 pm Sale | 2025-03-31 | 13G | The Clorox Company CLX | UBS Group AG | 0 0.000% | -10,084,448 (Position Closed) | Filing History |
| 2025-04-25 11:41 am Purchase | 2024-12-31 | 13G | The Clorox Company CLX | UBS Group AG | 10,084,448 8.200% | 10,084,448 (New Position) | Filing History |
| 2025-04-14 3:40 pm Sale | 2025-03-31 | 13G | UBS Group AG UBS | NORGES BANK | 139,886,962 4.000% | -36,137,490 (-20.53%) | Filing History |
| 2025-02-10 10:59 am Purchase | 2024-12-31 | 13G | Vipshop Holdings Limited VIPS | UBS Group AG | 15,943,270 18.300% | 14,338,948 (+893.77%) | Filing History |
| 2025-02-10 10:42 am Sale | 2024-12-31 | 13G | PIMCO Access Income Fund PAXS | UBS Group AG | 2,233,985 5.100% | -701,709 (-23.90%) | Filing History |
| 2025-02-10 09:26 am Purchase | 2024-12-31 | 13G | RENALYTIX PLC ADS RNLXY | UBS Group AG | 16,774,708 5.100% | 16,774,708 (New Position) | Filing History |
| 2025-02-10 09:13 am Sale | 2024-12-31 | 13G | Liberty Broadband Corporation LBRDK | UBS Group AG | 0 0.000% | -7,781,165 (Position Closed) | Filing History |
| 2025-02-10 08:59 am Sale | 2024-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | UBS Group AG | 0 0.000% | -21,491,881 (Position Closed) | Filing History |
| 2025-02-10 08:33 am Purchase | 2024-12-31 | 13G | Zeta Network Group ADD | UBS Group AG | 1,486 7.100% | 1,486 (New Position) | Filing History |
| 2024-11-08 12:14 pm Purchase | 2024-09-30 | 13G | UBS Group AG UBS | NORGES BANK | 176,024,452 5.080% | 176,024,452 (New Position) | Filing History |